Level I randomized prospective outcomes study comparing two groups of patients. One group
will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will
receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with
an infusion of 0.2% Ropivicaine post-operatively and a PCA.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute